SITC SITE Centers Corp.
NYSE · Real Estate
Tue, Nov 10
0.6× volume
+1.0%
Mon, Nov 9
1.6× volume
+0.8%
Fri, Nov 6
5.2× volume
+17.2%
Thu, Nov 5
4.0× volume
-84.7%
Wed, Nov 4
4.4× volume
+1.4%
Tue, Nov 3
0.8× volume
+0.0%
Mon, Nov 2
0.9× volume
-1.6%
News this week
- Immunofoco Presents a Novel In Vivo TCE Delivery Strategy Using Lentiviral Vectors at SITC 2026
- Antengene Presents Latest Preclinical Results of Novel Cos-TCE Platform AnTenGager‑D2 in Rapid Oral Abstract Presentation at SITC 2026
- Inimmune Presents Late-Breaking Phase 1 INI-4001 Results Demonstrating On-Target Immune Activation in Advanced Solid Tumors at SITC 2026
- OncoC4 Reports Encouraging Phase 1/2 Data for Cesalatamig Monotherapy in Previously Treated Non-Small Cell Lung Cancer at SITC 2026
- New Data for Precision Biologics, Inc. PB-223 ADC against novel tumor-specific target on human cancers revealed at SITC 2026
- Combinations of iOnctura's roginolisib revert immune suppression in immunotherapy-resistant NSCLC
- BriaCell and BriaPro Present Positive Preclinical Immunotherapy Data Across Four Posters at SITC 2026
- ImmunoGenesis to Present IND-Enabling Development Progress and Therapeutic Potential of IMGS-203, a Novel STING Agonist, at SITC 2026 Annual Meeting